Concepedia

Author

D C Bicknell

John Radcliffe Hospital

Also Known As

D Bicknell, D C Bicknell, D. Bicknell, D. C. BICKNELL, D. C. Bicknell, D.C. BICKNELL, D.C. Bicknell

31

Publications

2.3K

Citations

18

H-Index

56

Concepts

All Affiliations

John Radcliffe HospitalThe Honourable Society of Lincoln's InnBiparIndiana UniversityCancer Research UK
DC

About

D C Bicknell is an author at John Radcliffe Hospital specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

1K

2

Cell Biology

8

8

701

3

Allergy

3

3

139

4

Endocrinology

2

2

31

5

Public Health

1

1

13

D C Bicknell

×

19

Publications

2.1K

Citations

17

H-Index

YearCitations

<i>APC</i> mutations in sporadic colorectal tumors: A mutational “hotspot” and interdependence of the “two hits”

Andrew Rowan, H. Lamlum, Mohammad Ilyas,

Proceedings of the National Academy of Sciences

2000

502

Changes in cell surface antigen expression during hemopoietic differentiation

Colin A. Sieff, D C Bicknell, G. D. Caine,

Blood

1982

257

Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas

S Cottrell, Walter F. Bodmer, D C Bicknell,

The Lancet

1992

253

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway

K Woodford-Richens, Andrew Rowan, Patricia Gorman,

Proceedings of the National Academy of Sciences

2001

195

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.

Michael J. Browning, P. Krausa, Andrew Rowan,

Proceedings of the National Academy of Sciences

1993

172

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.

D C Bicknell, Andrew Rowan, Walter F. Bodmer

Proceedings of the National Academy of Sciences

1994

145

Mechanisms of loss of HLA class I expression on colorectal tumor cells

Michael J. Browning, Fiorella Petronzelli, D C Bicknell,

Tissue Antigens

1996

104

Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.

Hal E. Broxmeyer, Douglas E. Williams, Giao Hangoc,

Proceedings of the National Academy of Sciences

1987

102

Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Hal E. Broxmeyer, Douglas E. Williams, Stephanie Cooper,

Journal of Clinical Investigation

1987

101

Loss of CDX1 expression in colorectal carcinoma: Promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines

Newton A C S Wong, M. P. Britton, Gyu‐Seog Choi,

Proceedings of the National Academy of Sciences

2004

66

Page 1